Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent

Athanasios Zomas; Nicolaos Anagnostopoulos; Meletios A Dimopoulos

doi:10.1038/sj.bmt.1702444

Related publications

Letter2006

Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation

Meletios A Dimopoulos

Article2019

Multiple myeloma: Role of autologous transplantation

Ioannis Ntanasis‐Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios A Dimopoulos

Article2007

High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial

Christos Papadimitriou, Urania Dafni, Αchilles Anagnostopoulos, G. Vlachos, Zannis Voulgaris, Alexandros Rodolakis, Gerasimos Aravantinos, Aristotelis Bamias, George Bozas, Evangelos Kiosses, G.-M. Gourgoulis, Eleni Efstathiou, Meletios A Dimopoulos

Article2009

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

Antonio Palumbo, Orhan Sezer, Robert Kyle, Jesús F. San Miguel, Robert Z. Orlowski, Philippe Moreau, Rubén Niesvizky, Gareth J. Morgan, Raymond L. Comenzo, Pieter Sonneveld, Shaji Kumar, Roman Hájek, Sergio Giralt, Sara Bringhen, Kenneth Anderson, Paul G. Richardson, Michèle Cavo, Faith E. Davies, Joan Bladé, Hermann Einsele, Meletios A Dimopoulos,

Article2003

Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone

Meletios A Dimopoulos, C. Tsatalas, Athanassios Zomas, George Hamilos, Panayiotis Panayiotidis, Dimitris Margaritis, C. Matsouka, T. Economopoulos, Nicolaos Anagnostopoulos